Cascadian Therapeutics to Report Second Quarter 2017 Financial Results on August 8, 2017
August 01, 2017 08:30 ET | Cascadian Therapeutics, Inc.
SEATTLE, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that it will report its second quarter financial...
Cascadian Therapeutics Announces Positive Regulatory Update for Tucatinib in Europe
July 11, 2017 08:00 ET | Cascadian Therapeutics, Inc.
SEATTLE, July 11, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the outcome of discussions with the European...
China FDA Approves CTAs for BeyondSpring’s Second Global Plinabulin Registrational Trial for Chemotherapy-Induced Neutropenia Prevention
July 06, 2017 08:00 ET | BeyondSpring, Inc.
NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer...
Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention
June 22, 2017 11:54 ET | Exosome Diagnostics
Boston, MA, June 22, 2017 (GLOBE NEWSWIRE) -- John Boyce, President and CEO of Exosome Diagnostics Inc., a leader in the liquid biopsy space, presented a talk entitled “The True Liquid Biopsy”...
BeyondSpring to Present at the Jefferies 2017 Healthcare Conference
June 02, 2017 16:32 ET | BeyondSpring, Inc.
NEW YORK, June 02, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies,...
Cascadian Therapeutics to Present at Jefferies 2017 Healthcare Conference
May 31, 2017 08:30 ET | Cascadian Therapeutics, Inc.
SEATTLE, May 31, 2017 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that management will present at the Jefferies 2017...
IGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination Therapies
May 16, 2017 09:57 ET | India Globalization Capital
BETHESDA, Md., May 16, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE MKT:IGC) announces that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on...
BeyondSpring Chief Medical Officer to Present at Three Prominent Industry Conferences in May 2017
May 08, 2017 08:30 ET | BeyondSpring, Inc.
NEW YORK, May 08, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, announced...
BeyondSpring Enrolls First U.S. Patient in Phase 2/3 Clinical Trial of Plinabulin for Neutropenia Prevention
April 25, 2017 08:30 ET | BeyondSpring, Inc.
NEW YORK, April 25, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Launches ExpressMODEL™, a New Accelerated Model Generation Service
April 03, 2017 10:30 ET | Taconic Biosciences
HUDSON, N.Y., April 03, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, has launched ExpressMODEL™, an innovative and...